Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

155
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
155
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

289
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
289
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

439
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
439
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

238
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
238
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

151
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
151
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

114
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
114

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Østergaard Declaration: A European Society of Anaesthesiology and Intensive Care statement on advancing simulation-based education and training.

European journal of anaesthesiology·2026
Same author

Coronary vasomotor dysfunction and anesthesia management in noncardiac surgery.

Current opinion in anaesthesiology·2026
Same author

APECx-Anaesthesia, Perfusion and Surgical Practices in Cardiac Surgery: Main Study Protocol of a Modular Multiphase Prospective International Multicentre Observational Study.

Acta anaesthesiologica Scandinavica·2026
Same author

Impact of Preoperative Hemodynamic Values on Development of Reperfusion Edema After Pulmonary Endarterectomy.

Pulmonary circulation·2026
Same author

Eight strategic elements that support successful implementation of beneficial nutritional interventions in the perioperative setting: A systematic review.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Nurses' and Anesthesiologists' Perspectives on Family Involvement in the Care of Frail Older Patients in the Holding and Postanesthesia Care Unit: A Qualitative Study.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses·2025

Related Experiment Video

Updated: Nov 30, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.5K

Perioperative Cardioprotection: Clinical Implications.

Sebastian Roth1, Carolin Torregroza1,2, Ragnar Huhn1

  • 1From the Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany.

Anesthesia and Analgesia
|November 13, 2020
PubMed
Summary
This summary is machine-generated.

Perioperative cardioprotection strategies show promise in experiments but largely fail in clinical trials. This review examines why translating these cardioprotective therapies into improved patient outcomes remains challenging.

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.7K
A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

8.1K

Related Experiment Videos

Last Updated: Nov 30, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.5K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.7K
A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

8.1K

Area of Science:

  • Anesthesiology
  • Cardiovascular Research
  • Translational Medicine

Background:

  • Perioperative cardioprotection aims to mitigate myocardial ischemia-reperfusion injury.
  • Experimental studies identify promising cardioprotective treatments.
  • Clinical proof-of-concept studies show some success.

Purpose of the Study:

  • To review clinical evidence of perioperative cardioprotective therapies.
  • To highlight nonpharmacological and pharmacological strategies.
  • To discuss barriers in translating experimental findings to clinical practice.

Main Methods:

  • Review of available clinical evidence.
  • Analysis of anesthesiological perspectives.
  • Discussion of confounding factors in clinical trials.

Main Results:

  • Many cardioprotective strategies fail in large clinical trials.
  • Translating experimental results to improved clinical outcomes is disappointing.
  • Evidence for perioperative cardioprotection in improving patient outcomes is limited.

Conclusions:

  • Significant challenges exist in translating experimental cardioprotection to clinical practice.
  • Confounders hinder the success of large randomized controlled trials.
  • Future research needs to address limitations for improved perioperative patient outcomes.